VarmX

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Alveron Pharma

Alveron Pharma develops a cyclodextrin-based injectable drug that reverses anticoagulant and antiplatelet effects for patients experiencing life-threatening bleeding emergencies and haemorrhagic strokes.

RougeTx

This biotechnology company develops small-molecule therapies that restore vascular stability to treat patients with hereditary haemorrhagic telangiectasia and other bleeding disorders.

TargED

This biotechnology company develops targeted biological drugs that deliver enzymes to blood clots to treat patients with various forms of thrombosis.

ProFactor Pharma

This company develops recombinant Factor VIII to treat haemophilia A in patients who currently lack access to affordable medication.

Cayuga Biotech

This company develops biomimetic injectable drugs to control life-threatening hemorrhage for patients suffering from trauma, childbirth complications or surgical bleeding.